Optimising local therapy during oral surgery in patients with von Willebrand disease: Effective results from a retrospective analysis of 63 cases

Haemophilia

Volumn 6, Issue 2, 2000, Pages 71-77

  Federici, A B ^a,c   Sacco, R ^b   Stabile, F ^a   Carpenedo, M ^a   Zingaro, E ^b   Mannucci, P M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Istituto Stomatologico Italiano   (Italy)

^c Haemophilia and Thrombosis Centre   (Italy)

Author keywords

Desmopressin; Factor VIII Willebrand concentrates; Oral surgery; Tranexamic acid; von Willebrand disease

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; CALCIUM CHLORIDE; DESMOPRESSIN; ESMOSINT; FIBRIN GLUE; FIBRINOGEN; THROMBIN; TRANEXAMIC ACID; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CHILD; CONTROLLED STUDY; DENTAL SURGERY; FEMALE; HUMAN; MALE; MOUTHWASH; ORAL SURGERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DEAMINO ARGININE VASOPRESSIN; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; FACTOR VIII; FEMALE; FIBRIN TISSUE ADHESIVE; HEMORRHAGE; HEMOSTASIS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; ORAL HEMORRHAGE; ORAL SURGICAL PROCEDURES; PERIODONTAL DISEASES; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; TOOTH EXTRACTION; TRANEXAMIC ACID; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0034019803     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2000.00370.x     Document Type: Article

References (25)

1. Federici AB. Diagnosis of von Willebrand disease. Haemophilia, 1998; 4: 654-60.
2. Mannucci PM. Treatment of von Willebrand disease. Haemophilia, 1998; 4: 661-4.
3. Keila S, Kaufman A, Itckowitch D. Uncontrolled bleeding during endodontic treatment as the first symptoms for diagnosing von Willebrand's disease. Oral Surg Med Pathol 1990; 69: 243-6.
4. Federici AB, Mannucci PM. Actual management of von Willebrand disease (vWD): report on 1257 cases of the Italian Registry of vWD. (Abstract) Haemophilia 1998; 4 (3): 289.
5. Vinkier F, Vermylen J. Dental extractions in hemophilia. Reflections on 10 years experience. Oral Surg Med Pathol 1985; 59: 6-9.
6. Piot B, Fiks-Sigaud M, Ferri J, Gordeeff A, Mercier J. Les extractions dentaires chez les hémophiles et les porteurs de la maladie de Willebrand. Propositions thérapeutiques à propos de 26 observations. Rev Stom Chir Maxillof 1994; 95 (4): 263-7.
7. Vangelisti R, Pagnacco O, Ristagno G et al. Prevention of hemorrhage and dental treatment of patients with congenital or acquired coagulopathies. Minerva Stomatol 1997; 46 (11): 621-6.
8. Chiarini L, Bertoldi C, Narni F. Treatment of the patient with a coagulation defect in oral and maxillofacial surgery: III. The management of patients in a hypocoagulative state because of a hemophilic-type primary pathology. Minerva Stomatol 1997; 46 (3): 115-31.
9. Wilde JT, Cook RJ. von Willebrand disease and its management in oral and maxillofacial surgery. Br J Oral Maxillofac Surg 1998; 36 (2): 112-8.
10. Suzuki H, Takeuchi M, Sumi Y, Matsuda M, Shikomory M, Kaneda T. Local hemostatic of oral bleeding in patients with coagulopathie. Lancet 1983; 101: 362-3.
11. Sindet-Pedersen S, Stenbjerg S. Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery. J Oral Maxillofac Surg 1986; 44: 703-7.
12. Williamson R, Eggleston D. DDAVP and EACA used for minor oral surgery in von Willebrand disease. Aust Dent J 1988; 5: 332-6.
13. Sindet-Pedersen S, Ramstrom G, Bernvil S, Blomback M. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N EnglJ Med, 1993; 320: 840-3.
14. Rakocz M, Mazar A, Varon D, Spierer S, Blinder D, Martinowitz U, Hashomer T. Dental extractions in patients with bleeding disorders: the use of fibrin glue. Oral Surg Med Pathol 1993; 75: 280-2.
15. Waly NG. Local antifibrinolytic treatment with tranexamic acid in hemophilic children undergoing dental extractions. Egypt Dent J 1995; 41 (1): 961-8.
16. Martinowitz U, Shulman S. Fibrin sealant in surgery of patients with a hemorrhagic diathesis. Thromb Haemostas 1995; 74: 486-92.
17. Radivoyevitch MA. Hemophilia and EACA. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82 (2): 118.
18. Suwannuraks M, Chuansumrit A, Sriudomporn N. The use of fibrin glue as an operative sealant in dental extraction in bleeding disorder patients. Haemophilia 1999; 5: 106-8.
19. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
20. Djulbegovic B, Goldsmith GH. Guidelines for management of hemophilia A and B. Blood 1995; 85 (2): 598-9.
21. Saulnier J, Marey A, Horellou MH et al. Evaluation of desmopressin for dental extractions in patients with hemostatic disorders. Oral Surg Med Path 1977; 77: 6-12.
22. Castaman G, Lattuada A, Mannucci PM, Rodeghiero F. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease. Br J Haematol 1995; 89: 147-51.
23. Casonato A, Steffan A, Pontara E et al. Post-DDAVP thrombocytopenia in type IIB von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation. Thromb Haemostas 1998; 81: 224-8.
24. Bond L, Bevan D. Myocardial infarction in a patient with hemophilia treated with DDAVP (letter). N Engl J Med 1998; 318: 121.
25. Federici AB, Mannucci PM. Optimizing therapy with factor VIII/von Willebrand factor concentrates in von Willebrand disease. Haemophilia 1998; 4 (3): 7-10.